Physician profile
Stephen E Ward
NPI 1427268911
$5,822.98
in general payments reported to CMS, 2019-2025
28 companies · $611 in 2025
The $611 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,423 · 2020: $563 · 2021: $917 · 2022: $871 · 2023: $908 · 2024: $530 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,049.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,157.04 | 2019-2025 | Optis, Dragonfly Opstar, Xience Sierra |
| Novartis Pharmaceuticals Corporation | $846.43 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $639.80 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $476.77 | 2019-2025 | Farxiga, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $413.16 | 2019-2024 | Eliquis, Camzyos |
| Boston Scientific Corporation | $347.42 | 2019-2025 | Synergy, General - Balloon Catheters, Wolverine Coronary Cutting Balloon |
| Medtronic, INC. | $338.27 | 2021-2024 | Onyx Frontier |
| Boehringer Ingelheim Pharmaceuticals, INC. | $335.48 | 2019-2025 | Jardiance |
| Lantheus Medical Imaging, INC. | $258.38 | 2019-2025 | Definity |
| Amgen INC. | $128.20 | 2019-2021 | |
| Abiomed | $126.05 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $121.68 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $87.58 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $74.32 | 2025 | |
| Acist Medical Systems, INC. | $65.81 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $61.14 | 2019-2020 | |
| Pfizer INC. | $48.12 | 2019-2021 | |
| Amarin Pharma, INC. | $38.43 | 2019 | |
| Philips North America LLC | $34.02 | 2024-2025 | Coronary Other, (6366) Sync |
| Thrombolex, INC. | $33.08 | 2024-2025 | Bashir Endovascular Catheter |
| Terumo Medical Corporation | $32.40 | 2021-2024 | Glidesheath Slender, Angio-Seal |
| Kestra Medical Technology Services, INC. | $31.22 | 2024-2025 | Assure Wcd |
| Atricure, INC. | $29.98 | 2024 | |
| Penumbra, INC. | $26.03 | 2023-2024 | Indigo System |
| Novo Nordisk INC | $23.90 | 2025 | Wegovy |
| Heartflow, INC. | $18.62 | 2025 | |
| Merck Sharp & Dohme LLC | $16.55 | 2021 | |
| Gilead Sciences, INC. | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.